Soleno Therapeutics (SLNO) · page 93 of 415
The slide presents qualitative feedback from a medical expert, highlighting concerns about diabetes risk and comparing the drug to the Aduhelm controversy.
Activist deck · nominee_bio · introduce_nominees · dense density
Slide locked Sign in to view
Slide schematic 4/6
callout 0/1 list 2/2 quote 0/1 source-note 1/1 title 1/1
2 without position callout 1 · quote 1
calloutquote
Components 6
callout bullet bullet quote source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.